These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4241717)

  • 1. Fibrinogen breakdown products: identification and assay in serum and urine.
    Rayner H; Parashevas F; Israels LG; Israels ED
    J Lab Clin Med; 1969 Oct; 74(4):586-96. PubMed ID: 4241717
    [No Abstract]   [Full Text] [Related]  

  • 2. [Assay methods and significance of fibrin-fibrinogen degradation products in blood].
    Shinada S
    Nihon Ketsueki Gakkai Zasshi; 1972 Oct; 35(5):607-16. PubMed ID: 4677376
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antisera to fibrinogen degradation products, fragments D and E].
    Sudo T; Fujisawa M; Okumura H; Manita H
    Nihon Ketsueki Gakkai Zasshi; 1972 Oct; 35(5):652-3. PubMed ID: 4269798
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental study of rabbit fibrinogen degradation products. Influence of plasminogen level for the interpretation of serum concentration of fibrinogen degradation products in consumption coagulopathies.
    Soria J; Soria C; Vairel E; Prost RJ; Warneson G
    Thromb Diath Haemorrh; 1973 Feb; 29(1):115-21. PubMed ID: 4267735
    [No Abstract]   [Full Text] [Related]  

  • 5. The tanned red cell hemagglutination-inhibition immunoassay of fibrinogen-fibrin degradation products. Methodological and statistical aspects.
    Hahn L
    Thromb Res; 1974 Mar; 4(3):417-36. PubMed ID: 4857332
    [No Abstract]   [Full Text] [Related]  

  • 6. The staphylococcal clumping test for detection of fibrinogen-like material.
    Donati MB; Vermylen J; Verstraete M
    Scand J Haematol Suppl; 1971; 13():137-43. PubMed ID: 4258199
    [No Abstract]   [Full Text] [Related]  

  • 7. The Tanned Red Cell Hemagglutination Inhibition Immunoassay and purified fibrinogen degradation products.
    Donati MB; Molla A; Vermylen J
    Scand J Haematol Suppl; 1971; 13():91-9. PubMed ID: 4258208
    [No Abstract]   [Full Text] [Related]  

  • 8. The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage.
    Marder VJ; Shulman NR; Carroll WR
    Trans Assoc Am Physicians; 1967; 80():156-67. PubMed ID: 4230117
    [No Abstract]   [Full Text] [Related]  

  • 9. STUDY OF FIBRINOGEN TURNOVER RATES AFTER TOTAL HEPATECTOMY IN DOGS.
    GANS H
    Surgery; 1964 Apr; 55():544-50. PubMed ID: 14138019
    [No Abstract]   [Full Text] [Related]  

  • 10. The identification of fibrinogen derivatives in plasma and serum by agarose gel filtration.
    Vermylen J; Donati MB; Verstraete M
    Scand J Haematol Suppl; 1971; 13():219-23. PubMed ID: 4258201
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the significance of secondary fibrinolysis in experimental DIC (author's transl)].
    Goto H
    Nihon Seirigaku Zasshi; 1973 Jun; 35(6):295-306. PubMed ID: 4270923
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical evaluation of standard treatment with streptokinase in acute myocardial infarction.
    Gormsen J
    Acta Med Scand; 1972; 191(1-2):77-85. PubMed ID: 5032441
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum effects following tissue thromboplastin infusion.
    Astrup T; Albrechtsen OK
    Thromb Diath Haemorrh; 1969 Feb; 21(1):117-28. PubMed ID: 5773723
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific and sensitive determination of fibrinogen-degradation products by radioimmunoassay.
    Gordon YB; Martin MJ; McNeile AT; Chard T
    Lancet; 1973 Nov; 2(7839):1168-70. PubMed ID: 4127547
    [No Abstract]   [Full Text] [Related]  

  • 15. Improved method for measuring fibrinogen in plasma, with use of a plasmin inhibitor.
    Steffen LW; Steffen BW
    Clin Chem; 1976 Mar; 22(3):381-3. PubMed ID: 130214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An accelerated red-cell hemagglutination inhibition immunoassay for measuring fibrinogen degradation products in human serum.
    Fischer R; Furlan M; Beck EA
    Thromb Diath Haemorrh; 1971 Oct; 26(2):311-4. PubMed ID: 5167423
    [No Abstract]   [Full Text] [Related]  

  • 17. [Detection of fibrinogen and fibrin degradation products (FDP) and its clinical significance].
    Fujimaki M; Ikematsu S; Takeuchi I
    Nihon Rinsho; 1973 Apr; 31(4):798-804. PubMed ID: 4580396
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative study of adult and fetal sheep fibrinogen, sulf-fibrinogen and fibrinogen degradation products.
    Loly W; Israels LG; Bishop AJ; Israels ED
    Thromb Diath Haemorrh; 1971 Dec; 26(3):526-40. PubMed ID: 4259443
    [No Abstract]   [Full Text] [Related]  

  • 19. The results of a comparison of the tanned red cell hemagglutination inhibition immuno-assay with an immunochemical method for the determination of splitproducts.
    Bouma BN
    Scand J Haematol Suppl; 1971; 13():111-4. PubMed ID: 4258197
    [No Abstract]   [Full Text] [Related]  

  • 20. Electrophoretic pattern and reactivity of fibrinogen degradation products (FDP) in three assays.
    Niewiarowski S; Nandi M; Colman RW; Bloch KJ
    Scand J Haematol Suppl; 1971; 13():129-35. PubMed ID: 4258198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.